Title : Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome.

Pub. Date : 2022 Apr

PMID : 34894066






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Imatinib, a receptor tyrosine kinase (RTK) inhibitor, has been used in Penttinen syndrome (PS) patients with good results. Imatinib Mesylate ret proto-oncogene Homo sapiens
2 Imatinib, a receptor tyrosine kinase (RTK) inhibitor, has been used in Penttinen syndrome (PS) patients with good results. Imatinib Mesylate ret proto-oncogene Homo sapiens